Phenol

CHEMBL14060 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
94.1 g/mol
LogP
1.5
Phase
4

Phenol is a simple aromatic compound with antiseptic, disinfectant, local anesthetic, and cauterizing properties that acts by denaturing proteins and disrupting cell membranes at bactericidal concentrations. At low concentrations it has been used in throat sprays, ear drops, and topical analgesics, while at higher concentrations it serves as a chemical denervation and neurolytic agent in pain management procedures.

Peso Molecular

94,1100 g/mol

LogP

1,50

TPSA

20,20 Ų

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Mecanismo de Ação

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Oc1ccccc1

InChI

InChI=1S/C6H6O/c7-6-4-2-1-3-5-6/h1-5,7H

Molecular Formula

C6H6O

HBD / HBA

1 / 1

Ligações Rotacionáveis

0

Átomos Pesados

7

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

Phenol is a simple aromatic compound with antiseptic, disinfectant, local anesthetic, and cauterizing properties that acts by denaturing proteins and disrupting cell membranes at bactericidal concentrations. At low concentrations it has been used in throat sprays, ear drops, and topical analgesics, while at higher concentrations it serves as a chemical denervation and neurolytic agent in pain management procedures.

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Yes, Phenol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL14060. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 996. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.